A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female Volunteers

Acute Urticaria Clinical Trial

Status Completed

Clinical Trial Summary

The objective of this study was to investigate the pharmacokinetics (PK) of JDP-205 injection at 10 mg dose administered by intramuscular injection using various injection techniques in healthy male and female volunteers after a single dose administration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02045524
Study type	Interventional
Source	JDP Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	August 2011
Completion date	September 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02024152` - Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg	Phase 1
Completed	`NCT02935699` - Clinical Trial Comparing JDP-205 to Diphenhydramine Injection for the Treatment of Acute Urticaria	Phase 3
Completed	`NCT02023164` - Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria	Phase 3
Completed	`NCT02565680` - Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in Emergency	Phase 2/Phase 3